Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Venture Investors
AddedFeb 13, 2024
UpdatedJun 28, 2026
Venture Investors

Venture Investors

Operating

Venture Investors LLC: A US-based venture capital firm specializing in healthcare and technology sectors.

Location
Madison, WI, US
Founded
1997
Firm
Compare
Portfolio
Employees
Website

Venture Investors LLC is a venture capital firm focused on healthcare and technology sectors in the United States. Based in the Midwest, the firm leverages its proximity to renowned research universities to identify and invest in innovative ideas shaping the future of health and wellness. Their typical investment rounds range from seed to Series C, with a strong emphasis on Series A investments.

Notable portfolio companies include Akebia Therapeutics, HistoSonics, and Elephas. Venture Investors prides itself on its deep, thorough approach to investment, targeting extraordinary ideas that drive healthcare innovation. The firm offers portfolio companies access to its decades of proven success and expertise in the healthcare sector, positioning itself as a valuable partner in fueling the future of healthcare advancements.

Venture Investors - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments53
Current Portfolio Count27
Total Portfolio Exits1

Top Investment Stages

Series A23 (45.1%)
Series B11 (21.6%)
Series C8 (15.7%)
Series Unknown6 (11.8%)
Seed3 (5.9%)

Stage Mix

Series A 45%Series B 22%Series C 16%Series Unknown 12%Seed 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Elephas logo

Elephas

HistoSonics logo

HistoSonics

Delphinus Medical Technologies logo

Delphinus Medical Technologies

EnsoData logo

EnsoData

ViaLase logo

ViaLase

Eximis Surgical logo

Eximis Surgical

Health Scholars logo

Health Scholars

TERAL logo

TERAL

Invenra logo

Invenra

Flugen logo

Flugen

Elucent Medical logo

Elucent Medical

Madison Vaccines logo

Madison Vaccines

TAI Diagnostics logo

TAI Diagnostics

Thalchemy logo

Thalchemy

Prevacept Infection Control logo

Prevacept Infection Control

UpTo logo

UpTo

Tissue Regeneration Systems logo

Tissue Regeneration Systems

Nextt logo

Nextt

Akebia Therapeutics logo

Akebia Therapeutics

Netsocket logo

Netsocket

BlueWillow Biologics logo

BlueWillow Biologics

Juventas Therapeutics logo

Juventas Therapeutics

Euthymics Bioscience logo

Euthymics Bioscience

Mithridion logo

Mithridion

Nerites logo

Nerites

Venture Investors - Classification

Also Known As
  • Ideal Property Partners Limited
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end